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Abstract  
BACKGROUND: Many studies have shown that a relationship exists between quality of life (QoL) 
and resilience in breast cancer patients, but few studies present information on the nature of this 
relationship of resilience on QoL. Our aim was to examine the relationship between resilience and 
quality of life in breast cancer patients.  
METHODS: QoL was measured in 218 consequent breast cancer patients, with EORTC - QLQ 
Core 30 questionnaire, and EORTC QLQ-BR23. The resilience was measured with Connor 
Davidson Resilience Scale.  
RESULTS: The global quality of life was positively correlated with the levels of resilience (R = 0.39 
p < 0.001). All functional scales (physical, role, emotional, cognitive and social functioning was in a 
positive correlation with resilience. The symptoms severity (fatigue, nausea and vomitus, pain, 
dyspnea, insomnia, appetite loss, constipation, diarrhea, financial difficulties) was in negative 
correlation with resilience. Less resilient breast cancer patients reported worse body image and 
future perspective and suffered from more severe adverse effects of systemic therapy, and 
arm/breast symptoms.  
CONCLUSION: Our findings show that psychological resilience affects different aspects of health-
related quality of life. More resilient patients have significantly better quality of life in almost all 
aspects of QoL. 
 
 
 
Introduction 
 
Resilience 
Psychological resilience represents an ability 
of a person to protect his/her mental health when 
faced with adversity such is the cancer diagnosis. 
Adversity, through resilience mechanisms, can be 
reframed and become a possibility that one can learn 
and even benefit from. Psychiatry, as well as 
psychology, have repeatedly addressed the negative 
outcomes derived from cancer experience, such as 
depression, post-traumatic stress symptoms as well 
as anxiety [1]. But, very little is known about, what 
drives people to fight, survive and grow, when faced 
with cancer. When describing the cancer experience, 
one can approach resilience from several aspects [2]. 
We can approach to resilience as a baseline 
characteristic, a personality trait that enables 
individual to maintain mental health when exposed to 
stressful situation [3, 4]. People who are full of 
optimism, hope, are motivated and have solid social 
support system prior to the adversity, may be 
considered as more resilient [5, 6]. Second way of 
understanding resilience is to view it as a mechanism, 
which a person can use to adapt and protect good 
mental health [7]. Another way of understanding 
resilience is if we measure it as an outcome, as a 
consequence of adversity [8]. When resilience 
represents consequence, there is no way for an 
individual to know if he/she is resilient until faced with 
adversity.  
Cancer survivors, who are more optimistic 
and hopeful for the future, cope better with cancer and 
even experience personal growth [9-13]. We can 
expect that breast cancer survivors, who are married 
[14, 15], have bigger and better social support system 
[16-18], and have positive coping styles [19], to be 
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more resilient and experience more growth as benefit 
from cancer diagnosis.  
Resilience can change and modify over time, 
is affected by many different situations and adversities 
that a person overcomes in a lifetime. Resilience 
represents a newer concept, which deserves to be 
targeted from the beginning of life with cancer. 
Clinicians should spend more time and effort to create 
interventions that enable patients to foster their 
resilience [2]. 
 
Quality of life 
Cancer medicine has become increasingly 
effective, so the attention has shifted to issues 
surrounding cancer survivorship. The central 
challenge of cancer is still focused on being cancer 
free, but it is more and more important to maintain and 
improve the patients' quality of life [20].  When the 
concept of quality of life in cancer care emerged in the 
1980's, it was more understood as an issue of 
functionality and ability to effectively execute regular 
daily activities [21]. In time, the concept became 
broader and more aspects became integral part of 
contemporary QoL measurement, such as cognitive, 
emotional, social and sexual functioning.  
Many different factors influence quality of live 
in cancer patients and survivors. Individuals view the 
world from very different angles and they differ in their 
emotional and behavioural responses to adversity. 
Individual differences of cancer patients/survivors 
have important role in quality of life, in part because 
quality of life is shaped by some personality traits, not 
only by physical, socio-demographic and oncological 
variables [20].  
Understandably, the psychological distress 
that follows cancer diagnosis and treatment, 
negatively affects psychological components of QoL, 
in the beginning of cancer experience. What is not 
sufficiently explored is how much the initial 
psychological distress is influencing QoL of patients 
who are cancer survivors. Also the long-term side-
effects of breast cancer treatments on QoL are not 
conclusively confirmed nor dismissed. Is there a 
possibility that some psychological problems 
surrounding cancer become permanent in time? [22]. 
The future research should address these dilemmas 
and potentially highlight the individuals at risk.  
Most of the QoL research in cancer patients is 
focused on variables that negatively affect QoL 
domains (psychological distress, anxiety, depression, 
cognitive decline, insomnia, fatigue and other physical 
symptoms). The management of symptoms and 
disorders should occupy high position in the priority 
list, but it is also important to shift the focus from what 
declines QoL to what improves QoL, and do some 
more research on ways to help strengthen patients' 
resilience mechanisms.  
The aim of this study was to explore the 
association and the effect of resilience on health-
related quality of life in breast cancer patients. 
 
 
Methods 
 
Patients 
Patients from the oncology department of the 
Clinical Hospital "Dr. Trifun Panovski" in Bitola and 
University Clinic for Oncology and Radiotherapy in 
Skopje were included in this study. Participation in the 
study was offered to all patients who came for follow-
up in the oncology wards in Bitola and Skopje and 218 
patients met the inclusion criteria. All participants are 
women treated for breast cancer, older than 18 years, 
treated with different oncological therapies and are in 
a different time period from the initial cancer 
treatment. We used the following inclusion criteria: (1) 
women, aged between 18 and 90 years; (2) literate 
and fluent in Macedonian language; (3) no history for 
prior mental disorder; (4) histopathologically confirmed 
diagnosis of early breast cancer; (5) completed the 
initial surgical and oncological treatment at least 1 
month prior the inclusion. All participants have given 
written informed consent for participation in the study. 
The study was approved by The Ethics Committee for 
research on people at the Medical Faculty, University 
"St. Cyril and Methodius" in Skopje. 
 
Procedures 
All patients answered a questionnaire for 
psychosocial and oncological data specifically 
designed for the study. Some oncological parameters 
were collected from the medical data in the 
oncological wards. The psychological resilience was 
measured with Connor-Davidson Resilience Scale 25 
(CD-RISC25) [23, 24], a self-evaluation instrument 
with 25 items that are ranked on a Likert scale from 0 
to 4 points. The full range of the scale is 0-100 points, 
where higher scores indicate higher resilience. 
Health-related quality of life (HRQoL) was 
assessed with the Macedonian version of EORTC 
core quality of life questionnaire (EORTC QLQ-C30, 
version 3 together with the breast cancer module 
EORTC QLQ-BR23), which measures different 
aspects of quality of life relevant to patients with 
cancer. The EORTC QLQ-C30 questionnaire includes 
five functional scales (physical, role, cognitive, social, 
and emotional), nine symptom scales (nausea, pain, 
fatigue, dyspnoea, diarrhoea, constipation, insomnia, 
appetite loss, financial difficulties), and a global health 
scale. All scales range in score from 0 to 100. The 
EORTC QLQ-BR23 focuses on systemic therapy side 
effects, arm and breast symptoms, and includes 
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several sexual items. For functional scales, higher 
scores indicate better levels of functioning and/or 
better quality of life, while in symptom scales higher 
scores indicate more severe symptoms [25]. The 
sexual items were excluded from this analysis, due to 
small amount of valid data. 
 
 
Results 
 
In total, 218 participants, women with early 
breast cancer at an average age of 60.2 years (range 
30-90), were included in this study. The percentage of 
participants with primary school, high school, and 
university education levels were 25.8%, 40.6%, and 
33.6%, respectively. Almost half of the patients 106 
(49.5%) were retired, 58 (27.1%) were employed and 
50 (23.4%) were unemployed. Among the 218 
participants, 52 (27.9%) had I stage breast cancer, 74 
(39.8%) had second stage, and 60 (32.3%) had third 
stage breast cancer. Moreover, 72 (33%) patients 
underwent surgery combined with chemotherapy, 11 
(5%) underwent surgery combined with radiotherapy, 
104 (47.7%) underwent surgery combined with 
chemotherapy and radiotherapy, and 31 (14.2%) 
underwent only surgery. Most of the surgically treated 
patients underwent mastectomy 165 (77.8%), followed 
by lumpectomy 40 (18.9%) and double mastectomy 7 
(3.3%). In the moment of the interview 206 patients 
gave valid information about the adjuvant treatment: 
134 patients (65%) receive adjuvant therapy 
(tamoxifen 89.2% or aromatase inhibitors 10.8%). 
Most of the patients 86 (40.8%) were cancer free 
women for more that 5 years since initial diagnosis, 74 
(35.1%) were diagnosed 2-5 years ago, 28 (13.2%) 
were diagnosed 1-2 years ago, and 23 (10.9%) were 
diagnosed 6 months-1 year ago.  
The global quality of life was positively 
correlated with levels of resilience (R = 0.39, p < 
0.001). All functional scales were in positive 
correlation with resilience: physical functioning (R = 
0.3, p < 0.01), role functioning (R = 0.27, p < 0.01), 
emotional functioning (R = 0.49, p < 0.001), cognitive 
functioning (R = 0.39, p < 0.001) and social 
functioning (R = 0.4, p < 0.001).  
 
 
Figure 1: Correlation between global health/functioning scales and 
resilience 
When we analyzed the symptoms and the 
resilience we found that more resilient patients report 
less severe symptoms. The symptom severity is in 
negative correlation with resilience: fatigue (R = - 
0.363, p < 0.001), nausea and vomitus (R = - 0.3, p = 
0.000006), pain (R = - 0.3, p < 0.01), dyspnea (R = - 
0.29, p < 0.01), insomnia (R = - 0.352, p < 0.01), 
appetite loss (R = - 0.474, p < 0.001), constipation (R 
= - 0.217, p < 0.01), diarrhea (R = - 0.182, p < 0.01), 
financial difficulties (R = - 0.176, p < 0.01).  
 
Figure 2: Correlation between symptom severity and resilience 
 
Less resilient breast cancer patients reported 
worse body image (R = 0.35, p < 0.001) and future 
perspective (R = 0.369, p < 0.001). Also, less resilient 
patients suffered from more severe adverse effects of 
systemic therapy (R = - 0.366, p < 0.001), symptoms 
from arm (R = - 0.198, p < 0.01) and breast (R = - 
0.287, p < 0.01), as well as hair loss (R = - 0.3, p < 
0.01). 
 
Figure 3: Correlation between body image, future perspective, 
systemic therapy symptoms, breast/arm symptoms, hair loss and 
resilience 
 
 
Discussion 
 
Although a lot of research has shown that a 
resilience affects quality of life in cancer patients, data 
about the direction and the degree of this influence is 
not conclusive. The data obtained by our 
observational study showed that resilience is a major 
influencing factor in almost all aspects of QoL.  
The global quality of life was positively 
correlated with levels of resilience. All functional 
scales were in strong positive correlation with 
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resilience. Emotional, social, cognitive and role 
functioning were significantly better in more resilient 
patients. When we analyzed the symptoms and the 
resilience we found that more resilient patients report 
less severe symptoms. The symptom severity 
(fatigue, nausea and vomitus, pain, dyspnea, 
insomnia, appetite loss, constipation, diarrhea, 
financial difficulties) is in strong negative correlation 
with resilience. Less resilient breast cancer patients, 
as opposed to more resilient patients, had worse body 
image and their outlook on life was more pessimistic. 
Also, in less resilient patients physical functioning was 
worse and they had more severe adverse effects of 
systemic therapy and arm/breast symptoms.  
Beyond doubt, we cannot determine the 
direction of the influence of resilience and QoL on 
each other based on our data. It would be an over-
simplification of the complex psychological life of the 
cancer patients, to assume that QoL is affected only 
by the patients' psychological resilience. A lot of other 
psycho-social and oncological variables affect QoL. 
Their complex interplay should be taken into account. 
Nevertheless, resilience as a stable individual 
resource, has its own role into QoL improvement, that 
should be taken into account. Through analyzing the  
QoL of patients with cancer, we should select the 
most effective strategies that can improve patients' 
resilience [26]. The continued development of 
individual and group-based interventions that support 
positive outcomes and more functional coping styles 
[27] may be valuable and contribute to our 
understanding of resilience among cancer survivors. 
Our investigation shows that patients who are less 
depressed have higher levels of resilience and that 
psychological resilience may independently contribute 
to lower levels of depression among breast cancer 
patients. The level of psychological resilience may be 
a protective factor for depression and psychological 
distress [28]. Through endorsing patient's strengths, 
we can help the increase of quality of life.  
In conclusion, our findings show that 
psychological resilience affects different aspects of 
health-related quality of life. More resilient patients 
have significantly better quality of life in almost all 
aspects of QoL. These results can be used as a base 
for development of psychosocial interventions that will 
target psychological resilience in cancer patients.  
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